XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 11,306,685
Accounts receivable, net 30,739 30,714
Other receivables 34,964 108,815
Inventory 208,715 203,011
Prepaid expenses 270,150
Total current assets 11,851,253 342,540
Other assets    
Property and equipment, net 277,948 337,241
Other assets 14,262 14,262
Total assets 12,143,463 694,043
Current liabilities    
Accounts payable 836,155 861,840
Accrued expenses 197,836 123,639
Loan payable – related party 26,000
Total current liabilities 1,033,991 1,011,479
Non-current liabilities    
Non-convertible promissory notes 1,645,000 2,431,730
Convertible notes 1,105,000
Total non-current liabilities 1,645,000 3,536,730
Total liabilities 2,678,991 4,548,209
Commitments and contingencies (Note 12)
Stockholders’ equity (deficit)    
Preferred stock, $0.00001 par value; 20,000,000 shares authorized; 0 and 5,791,665 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 58
Common stock, $0.00001 par value; 80,000,000 shares authorized; 11,886,379 and 4,864,862 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 119 49
Additional paid-in capital 22,481,066 6,856,020
Accumulated deficit (13,016,713) (10,710,293)
Total stockholders’ equity (deficit) 9,464,472 (3,854,166)
Total liabilities and stockholders’ equity (deficit) $ 12,143,463 $ 694,043